Literature DB >> 4067181

Reflex patterns in postganglionic vasoconstrictor neurons following chronic nerve lesions.

H Blumberg, W Jänig.   

Abstract

Lesions of limb nerves in man may be associated with a variety of painful disorders with trophic changes described by the generic term 'reflex sympathetic dystrophy'. Our hypothesis is that pain and trophic changes are produced by an abnormal discharge pattern in postganglionic neurons supplying the limb (see refs. 3,24). In relation to this hypothesis, reflex patterns in postganglionic vasoconstrictor neurons supplying the skin (CVC) and the skeletal muscle (MVC) of the cat hindlimb were investigated at various times after a peripheral nerve lesion had been produced. These reflex patterns were compared with those in animals without nerve lesions (control preparations). The following lesions were made: cutting and ligating the superficial peroneal nerve (skin nerve) with subsequent neuroma formation, suturing the central stump of the superficial peroneal nerve to the peripheral stumps of muscle branches of the deep peroneal nerve, suturing the central stumps of muscle branches of the deep peroneal nerve to the peripheral stump of the superficial peroneal nerve, cutting and resuturing the superficial peroneal nerve, deafferentation of the whole hindlimb. The responses of vasoconstrictor neurons to stimulation of arterial chemoreceptors, arterial baroreceptors (cardiac rhythmicity of postganglionic activity) and cutaneous nociceptors were tested. In the animals with nerve lesions, the following groups of postganglionic vasoconstrictor neurons were analyzed: neurons projecting to the lesioned nerve, neurons projecting to hairy skin through an intact skin nerve (sural nerve) and neurons projecting to skeletal muscle through intact muscle nerves. In control preparations without nerve lesions, MVC neurons were excited by stimulation of arterial chemoreceptors and cutaneous nociceptors and inhibited by stimulation of arterial baroreceptors. Most CVC neurons were inhibited by stimulation of chemoreceptors and nociceptors and weakly inhibited by stimulation of baroreceptors. In animals with nerve lesions a and b, many CVC neurons in the lesioned nerves, as well as in the non-lesioned cutaneous nerve nearby, behaved in the same manner as MVC neurons. With respect to the control, this difference proved to be statistically significant. In preparations with lesions a, b and c, MVC neurons did not change their reflex patterns. After nerve lesions d and e, no major changes of reflex patterns were observed in CVC and MVC neurons. The inhibitory influence of arterial baroreceptors on CVC activity decreased in deafferented preparations (lesion e).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4067181     DOI: 10.1016/0165-1838(85)90073-6

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  6 in total

Review 1.  Complex regional pain syndromes.

Authors:  R Baron; G Wasner
Journal:  Curr Pain Headache Rep       Date:  2001-04

2.  Plasticity of sympathetic reflex organization following cross-union of inappropriate nerves in the adult cat.

Authors:  W Jänig; M Koltzenburg
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

Review 3.  Reflex sympathetic dystrophy: a sympathetically mediated pain syndrome or not?

Authors:  M Stanton-Hicks
Journal:  Curr Rev Pain       Date:  2000

Review 4.  [New viewpoints on the clinical picture, diagnosis and pathophysiology of reflex sympathetic dystrophy (Sudeck's disease)].

Authors:  H Blumberg; H J Griesser; M Hornyak
Journal:  Unfallchirurgie       Date:  1990-04

5.  [Sympathetic nervous system and pain: ideas, hypotheses, models.].

Authors:  W Jänig
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

6.  [Development and therapy of the pain syndrome of reflex sympathetic dystrophy. Clinical expression, experimental investigations, and new pathophysiological considerations.].

Authors:  H Blumberg
Journal:  Schmerz       Date:  1988-09       Impact factor: 1.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.